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ABSTRACT: Herein we report a simple fluorescence micros-
copy methodology that, jointly with four photosensitizers (PSs)
and a cell viability marker, allows monitoring of phenotypic
bacterial resistance to photodynamic inactivation (PDI) treat-
ments. The PSs, composed of BODIPY dyes, were selected
according to their ability to interact with the cell wall and the
photoinactivating mechanism involved (type I or type II). In a
first approach, the phenotypic heterogeneity allowing bacteria to
persist during PDI treatment was evaluated in methicillin-
resistant Staphylococcus aureus (MRSA) and Escherichia coli as Gram-positive and Gram-negative models, respectively. By means
of propidium iodide (PI), we monitored with spatiotemporal resolution cell viability at the single bacterium level. All the PSs
were effective at inactivating pathogens; however, the cationic nonhalogenated PS (compound 1) surpassed the others and was
capable of photoinactivating E. coli even under optimal growth conditions. Compound 1 was further tested on two other Gram-
negative strains, Pseudomonas aeruginosa and Klebsiella pneumoniae, with outstanding results. All bacterial strains used here are
well-known ESKAPE pathogens, which are the leading cause of nosocomial infections worldwide. Thorough data analysis of
individual cell survival times revealed clear phenotypic variation expressed in the cell wall that affected PI permeation and thus
its intercalation with DNA. For the same bacterial sample, death times may vary from seconds to hours. In addition, the PI
incorporation time is also a parameter governed by the phenotypic characteristics of the microbes. Finally, we demonstrate that
the results gathered for the bacteria provide direct and unique experimental evidence that supports the time−kill curve profiles.
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single cell
Antibiotics have revolutionized the world of science andmedicine. Since 1940, antibiotics have been produced to
eliminate pathogenic microorganisms. However, microbes have
developed the ability to overcome these treatments with
specific mutations on the targets, resulting in changes in
bacterial susceptibility.1−4 Statistics indicate that multidrug-
resistant (MDR) bacteria, called “superbugs”, could cause
more than 10 million deaths worldwide by the year 2050 and
have an estimated global economic burden of US$100 trillion.5
In response to this latent threat, scientists have begun to
develop alternative therapies, such as photodynamic inactiva-
tion (PDI), which emerged late in the 20th century as a
promising treatment for killing pathogens. PDI requires the
combination of light, a photosensitizer (PS), and molecular
oxygen. Upon irradiation of the PS, the excited singlet state
(S1) is populated and can undergo fast intersystem crossing
(ISC) to a long-lived excited triplet state (T1). From T1,
electron transfer or energy transfer can occur, giving rise to
what are known as type I and type II photoprocesses,
respectively.6 The former involves an electron transfer process
generating superoxide anion radicals (O2
·−) that can be
reduced to hydrogen peroxide (H2O2) and subsequently
induce the highly toxic hydroxyl radicals (OH·) by Fenton
chemistry. The type II mechanism uses energy transfer to
generate singlet oxygen (1O2).
6−8 In both cases, cytotoxic
reactive oxygen species (ROS) are produced with the ability to
oxidize lipid bilayers, DNA, proteins, and other biomolecules.9
ROS in cells can be formed by endogenous and exogenous
sources.10,11 Endogenous oxidants are produced as byproducts
of aerobic metabolism. On the other hand, exogenous ROS
refers to oxidants that are induced by extracellular factors such
as ultraviolet light, chemotherapeutics, and environmental
toxins, among others.10 Nevertheless, ROS levels within certain
boundaries are essential for maintaining cellular homeostasis,
and many of them act as signaling molecules.12,13 Regardless of
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their origins, when these oxidants exceed safe limits, they
became cytotoxic, affecting physiological functions.
Bacteria have different strategies to overcome the effects of
drugs. The antibiotic response of a strain is classified as
susceptible, tolerant, resistant, and persistent.14 A bacterial
culture is susceptible when the whole population is inhibited or
killed by the presence of an antibiotic. The term resistant is
associated with the failure of the antimicrobial therapy.15
Unlike resistant microbes, persistence defines a genetically
identical bacterial population in which a subpopulation (∼2%)
is not susceptible to the therapy.14,16−18 This subpopulation
can undergo transient and reversible changes in the bacterial
phenotype that confer resistance to the antibiotic.14 It has been
demonstrated that the ability of persister cells to survive for
longer periods is directly related to sporadic changes in gene
expression, which modifies the properties of the cellular
envelope.16 Also, gene expression can affect the influx and
efflux of solutes through membrane permeability, enabling
bacteria to inhabit different and often hostile environ-
ments.19,20 All of these factors are phenotypically expressed
in each bacterium, revealing a particular composition of the cell
wall.
The above definitions are solely for bacteria treated with
antibiotics; however, there is no clear terminology in the PDI
field. In this manuscript, we will be referring to the PDI
treatment resistance of a bacterium within a subset of a
genetically and metabolically identical bacterial population.
Specifically, resistance in this work will point out the ability of
microbes to endure different periods of treatment through
phenotypic variations. It is our eagerness to demonstrate how
bacterial survival times depend on the phenotype. We aim to
visualize in real-time shorter and longer living individuals
during a specific inactivation therapy.
To achieve our goal, we carefully selected four BODIPY-
derivative PSs with different photodynamic mechanisms and
specific binding groups, along with a well-known cell-death
marker, propidium iodide (PI). PI is an effective indicator dye
that becomes fluorescent upon intercalating with DNA.21
Staining with red emitting PI depends directly on cell
membrane permeability and is commonly used to evaluate
cell viability.22,23 As a proof of concept, we studied the
following bacterial strains: methicillin-resistant Staphylococcus
aureus (MRSA) as a Gram-positive model and Escherichia coli,
Pseudomonas aeruginosa, and Klebsiella pneumoniae as Gram-
negative models. These four strains are members of the well-
known ESKAPE pathogens, which are the leading cause of
nosocomial infections throughout the world.24
The simple experimental methodology described herein
allowed us to monitor heterogeneity at the spatiotemporal level
in the survival times of individual cells. This consequence is
mainly due to phenotypic variations expressed in the cell wall,
resulting in increased or reduced resistance toward photo-
oxidation.
■ RESULTS AND DISCUSSION
Selection and Design of the PSs. To pursue our goal, we
choose four BODIPY-derivative photosensitizers. These
compounds are shown in Figure 1, and each of them has a
distinct characteristic. Compound 1, identified by a relatively
low fluorescence quantum yield (Φf) compared with those of
the other nonhalogenated BODIPY analogues and a negligible
singlet oxygen quantum yield (ΦΔ) has proven to be an
effective ROS generator through a type I photoprocess.25,26
Subsequently, we replaced the hydrogen atoms at positions 2
and 6 in compound 1 with bromine atoms with the intention
of promoting a type II photomechanism via a heavy-atom
effect,27−31 obtaining compound 2. Also, compounds 1 and 2
were designed to selectively bind to the cell wall by means of
the cationic N,N,N-trimethylamino p-phenylene unit at the
meso position of the BODIPY core.25 On the other hand,
compound 3 has a high photostability and a ΦΔ value close to
unity, revealing a type II photooxidation mechanism and good
photoinactivating capability.32 It can also form hydrogen bonds
because of the presence of a meso-acetoxyacetyl substituent.
The last PS, compound 4, was designed with a pentafluor-
ophenyl (PFP) ring at the meso position of the BODIPY core,
which also included heavy atoms. The presence of fluorine
atoms increases cytotoxicity by binding to membrane-
embedded proteins. The PFP group readily undergoes a
regiospecific nucleophilic replacement of the para-fluorine
atom by a diverse set of nucleophiles.33
Photophysical Studies. The spectroscopic properties of
BODIPYs 1−4 in acetonitrile are listed in Table 1. The main
absorption band of compound 1 is centered at ∼500 nm. The
presence of bromine atoms at positions 2 and 6 produced a
bathochromic shift of ∼20 nm for compound 2 and ∼40 nm
for compounds 3 and 4 (Figure S1). This band was attributed
to a strong S0 → S1 transition.
34,35 Furthermore, it is possible
to distinguish the typical shoulder at 470 and 500 nm assigned
to the 0−1 vibrational band of the same transition. Moreover,
moving to the cyan zone of the spectrum, a second band at
∼370 nm, attributed to the S0 → S2 transition, can be
visualized. The fluorescence emission spectra of compounds
1−4 were also compared in acetonitrile. The bands are shown
in Figure S1 and correspond to the S1 → S0 transition, where
the presence of bromine resulted in a red-shift as a result of the
resonance donating effect of the heavy atom.
All compounds evidenced a high molar extinction coefficient
(∼70−80 × 103 M−1 cm−1); in accordance with intersystem
crossing taking place, compounds 3 and 4 are characterized
with the lowest values of Φf and the highest values for ΦΔ
(Table 1). However, despite having bromines and a low Φf,
compound 2 also has a low ΦΔ, which could be attributed to
aggregation of the dye in acetonitrile.36 Compound 1
presented low 1O2 production, in agreement with a type I
photomechanism as was previously demonstrated.25,26 As will
be discussed below, in the present work, by using the
fluorescent reporter 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCFDA), we elucidated that within the cellular micro-
environment, both PSs proceed mainly through a type I
pathway.
Finally, to compare PS efficacies, experimental conditions
were optimized to adjust the number of absorbed photons
during the irradiation process.
Figure 1. Compounds prepared and used in this work. Compounds 1
and 2 operate mainly through a type I mechanism, whereas
compounds 3 and 4 involve a type II mechanism.
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PS Effectiveness at Eliminating Pathogens. To
evaluate PS efficacy and subsequently the phenotypic
heterogeneity of resistance of a bacterium to the treatment,
we monitored bacterial death for the four PSs in two well-
studied bacterial strains: Gram-negative E. coli ATCC 25922
and Gram-positive methicillin-resistant S. aureus ATCC 43300
(MRSA). Movies with millisecond precision monitoring PI
incorporation into cells were recorded until the maximum
fluorescence intensity was reached for all bacteria in the
imaging region. For each movie recording fluorescence from PI
incorporation, a phase contrast image was acquired before and
after the PDI treatment. These allowed us to carefully select
only the bacteria that remained attached to the glass surface
from the beginning to the end of the experiment (Figure 2A).
Bacteria that were detached from the surface, out of focus,
showing fluorescence from the beginning (i.e., dead prior to
treatment), or freely diffusing in solution even after careful
washing of the chamber several times were not considered in
the analysis. By fitting the fluorescence intensity versus time
trajectories (Figure 2B) for each bacterium with a sigmoidal
equation (eq S1) and by extrapolation, we defined the initial
and final times. Here, the initial time refers to the time when
the intensity enhancement begins; hence, we considered this
the time at which the PS had elicited enough damage on the
membrane so as to permit PI incorporation and DNA binding..
On the other hand, we can say that bacterial death is reached
when the fluorescence enhancement reaches maximum (see
Video S1), which was denoted as the final time. In addition,
Table 1. Photophysical Properties of Compounds 1−4 in Acetonitrile at Room Temperature
compound absorption λmax (nm) emission λmax (nm) ε × 10
3 (M−1 cm−1) Φf ΦΔa
1 502 513 85 0.29 ± 0.02 0.09 ± 0.02
2 524 543 70 0.15 ± 0.02 0.11 ± 0.02
3 543 562 81b 0.14 ± 0.02b 0.79 ± 0.02
4 543 561 82 0.15 ± 0.02 0.75 ± 0.02
aSinglet oxygen quantum yields calculated from the consumption of 9,10-dimethylanthracene using Rose Bengal as a standard. ΦΔ(RB) = 0.54.
37
Errors are from triplicate experiments. bValue obtained from ref 32.
Figure 2. (A) Microscope setup developed for this work. After 30 min of incubation, the sample chamber was rinsed several times, leaving only
bacteria attached to the glass surface. E. coli cells, in this case, were then exposed to 1 μM PI to evaluate cell viability and were inactivated with 1
μM compound 3 after 20 min of incubation in air-equilibrated PBS saline buffer (see Figure S9 for control experiments). (B) Normalized
fluorescence intensity as a function of irradiation time. Fitting of the data according to eq S1 is shown by the continuous red line. The black straight
lines define the initial time, the final time, and Δt = final time − initial time. The power of the incident light was 0.7 J/cm2.
Figure 3. E. coli treated with compound 3 in the presence of PI. (A) Filmstrips corresponding to three different bacterial cells advancing (top to
bottom) from more labile to more resistant. Fluorescence is due to PI incorporation. (B) Normalized fluorescence intensity as a function of
irradiation time. Colored traces differentiate each bacterium in the filmstrips. Filmstrips and intensity profiles were extracted from Video S1.
Control experiments are shown in the Supporting Information (Figure S9).
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the difference between the final and initial times (Δt) was also
calculated, giving insight into how long it takes PI to permeate
through the cell envelope.
A total of one hundred traces for each bacterial strain
coming from randomly selected bacteria were gathered and
analyzed to generate plots. This approach provided statistic
information about different bacterial survival times due to
phenotypic differences and PS efficacy upon therapy. As it is
possible to appreciate in Video S1 (100× time-lapse), every E.
coli bacterium has a singular response to the photodamage
capability of the PS (compound 3 in this case) and hence PI
incorporation. This heterogeneity within the bacterial sample is
better appreciated in Figure 3, which shows filmstrips and
intensity profiles extracted from Video S1 at different times for
three individual cells from the sample chamber. At this point,
we want to remark that first, the bacterial sample came from a
pure culture originating from one single isolated colony, and
thus all bacteria were genetically identical, and second, to
ensure that the bacteria were in the same metabolic state,
strains were cultured until they reached halfway to stationary
phase.38−40
In comparison with flow cytometry (another experimental
methodology commonly used for cell analysis), our exper-
imental setting is a much simpler41 technique based on
fluorescence microscopy, with monitoring cells in real-time
with fluorogenic probes; it is also possible to apply more than
one dye with the addition of just a band-pass filter. We also
point out a disadvantage: bacterial attachment to the glass
surface depends on bacterial gender and the media employed.
The statistical information gathered from the movies for the
experiments with E. coli and MRSA are assembled in Figure 4.
In this figure, column a represents the correlation between the
final and initial times, with each bacterium represented by a
square in the scatter plot. These plots are also provided with a
continuous black line that represents the case in which PI
incorporates immediately upon PS-mediated photooxidation,
meaning Δt = 0. As is easily appreciated in Figure 4, this is not
true in our case.
Figure 4. Statistical analysis for E. coli (light blue, left) and MRSA (light orange, right). Column a: scatter plots showing the correlations between
the final and initial intensities. The continuous black lines were added to guide the eye and represent the cases where PI incorporates immediately
(Δt = 0). Column b: bacterial counts as functions of the initial (cyan) and final (orange) times. Rows display the compound utilized for each
treatment. The light doses applied for these experiments were between 0.04 and 3.4 J/cm2.
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Figure 4 column b shows 3D histograms representing the
bacterial counts as functions of the initial (cyan) and final
(orange) times. Rows indicate the compound that was used for
each treatment. Figure 4 will be the main object of discussion
in this paper.
Figure 4, particularly the scatter plots (column a), clearly
displays that differences in bacterial inactivation times due to
phenotypic heterogeneity are always present during PDI
treatment but in different magnitudes. These distributions in
the survival times are directly related to the PS, and that is why
we will first emphasize PS efficacies in achieving membrane
damage. After that, we will focus on highlighting the
heterogeneity of bacterial survival due to phenotypic differ-
ences.
The variations in the initial and final times for the same
bacterial strain are directly related to the PS effectiveness, for
which uptake plays a crucial role. Therefore, we measured dye
uptake, monitoring PS fluorescence and using an experimental
approach with similar conditions to those applied during PDI
experiments at the microscope (see the Material and Methods
in the Supporting Information). Uptake studies for the four
PSs with E. coli and MRSA are shown in Table S1. For E. coli,
108 cells incorporate 0.4 nmol of PSs 1 and 2, which is ∼1.3
and 2 times more than the levels for compounds 3 and 4,
respectively. In contrast, studies in MRSA show that
compounds 3 and 4 exhibit uptake values 2 times higher
than those of compounds 1 (0.3 nmol for 108 cells) and 2 (0.4
nmol for 108 cells). Moreover, similar binding was found for
cationic PSs 1 and 2 in both bacteria, whereas considerable
increases were obtained for 3 and 4 in S. aureus cells with
respect to those in E. coli cells.
The results can be explained by looking at the differences in
the compositions of the outer envelopes between the Gram-
negative and Gram-positive models. Specifically, the cell wall of
Gram-positive bacteria are formed by two layers, a lipid bilayer
and a thick peptidoglycan layer (30−100 nm) containing
teichoic acid.42 Overall, this barrier has a negative net charge
and is permeable because it is relatively porous.43 In contrast,
in Gram-negative bacteria, the cytoplasm is protected by an
inner lipid membrane and a highly complex multilayered
structure constituted by a compacted peptidoglycan film (2−
10 nm) to which the outer membrane is attached.44 The outer
membrane presents an asymmetric lipid structure formed by
negatively charged lipopolysaccharides (LPS), lipoproteins,
and proteins with porin functions. Molecules of LPS yield a
polyanionic external surface, which is partially neutralized by
the divalent cations Mg2+ and Ca2+.43,45,46 Thus, compounds 1
and 2, bearing cationic groups, can penetrate deeper into the
outer membrane of E. coli and produce tight electrostatic
interactions with negatively charged sites. This effect can
increase the photocytotoxicity mediated by the PSs. In
contrast, compounds 3 and 4 can bind through either
hydrogen bonds or covalent interactions with the peripheral
polysaccharide groups on the LPS chains. In consequence,
besides the higher binding values, ROS are more cytotoxic
when they are produced by compounds 1 and 2 because they
are located in close proximity to lipids and membrane-
embedded proteins. This is not the case with compounds 3
and 4, which produce 1O2 on the periphery. As aforemen-
tioned, Gram-positive bacteria have a thicker and porous
peptidoglycan layer that can uptake better compounds 3 and 4.
In fact, PS 3, because of its reduced size, can probably
penetrate dipper into the outer membrane, producing major
damage. Nevertheless, the amphiphilic characters of com-
pounds 1 and 2 not only increase their solubility in biological
environments but also enhance binding and penetration into
microbial cells.47
As expected by the cell wall composition, the PSs inactivated
MRSA in less time than they did E. coli. Specifically,
compounds 1, 2, 3, and 4 annihilated MRSA 11, 16, 14, and
5 times faster than they did E. coli (Table 2, final times,
maximum values). This is also visualized well in the supporting
videos (Videos S2 and S3, 100× time-lapse), which show E.
coli and MRSA inactivation with compound 1. Another factor
to be considered here is the mechanism by which the PS
generates the photodynamic action. ROS produced through a
type I mechanism are longer living than 1O2, and hence they
can diffuse longer and attack a larger number of biomolecules.7
In particular, Hamblin and co-workers hypothesized that PSs
operating through a type I mechanism are better at killing
Gram-negative bacteria than those operating through a type II
mechanism. They proposed that 1O2 could diffuse better into
the porous cell walls of Gram-positive bacteria, whereas the
less permeable Gram-negative bacterial outer envelope needs
the more reactive radicals to cause real damage.48,49 In order to
predict and visualize the radical pathway that takes place within
Table 2. Photoinactivation Data for E. coli and MRSA Treated with Compounds 1−4
E. coli
Δt (s) final time (s)
compound mean min max rangea mean min max rangea
1 530.6 181.7 866.5 684.7 1515.1 192.2 2281.6 2089.4
2 632.9 286.5 1168.8 882.0 1717.76 800.2 2879.2 2079.1
3 1103.9 295.9 2639.8 2343.8 2820.8 491.8 5429.0 4937.2
4 1379.5 440.3 2484.8 2044.5 4241.4 2061.8 5784.5 3722.7
1 (M-9) 706.1 111.1 1967.0 1855.9 4369.2 1057.5 6779.3 5721.8
MRSA
Δt (s) final time (s)
compound mean min max rangea mean min max rangea
1 31.1 4.2 91.5 87.4 71.1 8.2 211.6 203.4
2 63.3 66.1 168.2 102 136.4 78.3 175.9 97.2
3 160.7 40.6 281.3 240.8 226.1 44.9 384.5 339.6
4 385.6 95.4 769.0 673.6 790.3 331.0 1252.6 921.6
aOne-way ANOVA was applied to indicate statistical significance at P < 0.001.
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the cells, we performed assays using the same experimental
approach but with prior incubation with the ROS fluorogenic
quencher H2DCFDA.
50
The results show that the probe reached a maximum
intensity in only 200 s when E. coli was treated with compound
1 (see Figure S19). On the other hand, no fluorescence
enhancement was observed when compound 3 was used for
the therapy. Interestingly, inactivation with compound 2 also
showed fluorescence after 550 s of irradiation. This assay
revealed that the mechanisms taking place within the bacterial
environment are mainly type I for compounds 1 and 2.
We mentioned above higher phenotypic resistance to PDI
therapy, which we attributed to differences in the bacterial wall.
However, another possibility is that the phenotypic variation
affects the uptake of the PS, resulting in differential membrane
damage by ROS and variations in PI permeation. To evaluate
this second possibility, uptake assays of compound 3 in E. coli
were also performed at the single bacterium level but without
PI. All bacteria reached the same fluorescence intensity in less
than 5 min, indicating that phenotypic differences did not
affect PS uptake (Video S4). A third factor that could be
mediating the differences in cell killing is the intrinsic bacterial
defense systems (enzymatic and nonenzymatic).51 The most
well-characterized and studied bacterial model is E. coli, where
scavenging systems are enough to protect the cell under an
aerobic environment.52,53 Although hazardous exogenous
sources, such as PDI, elevate the rates of ROS triggering in
the cell, it was observed that under such conditions, the levels
of the bacterial defenses become insufficient.53
Given the success of compound 1, we subsequently tested its
PDI capabilities in two other Gram-negative strains, a reference
Pseudomonas aeruginosa strain (ATCC 27853) and a clinical
strain of Klebsiella pneumoniae. Together with E. coli and
MRSA, we selected these four strains, all ESKAPE pathogens,
because of the elevated numbers of nosocomial infections
reported in the last few years and because of their ability to
present MDR phenotypes. In February 2017, the World Health
Organization launched a list of antibiotic-resistant priority-
pathogens for which we are in imminent need of the
development of new drugs or therapies to battle against
them;54 our strains are included on the list. A full
representation of the results obtained with compound 1 and
all the Gram-negative bacteria treated here are represented in
Figure S3. In this figure, as well as in all the figures showing
statistical data in this work, analysis for each bacterial strain is
represented by a colored pattern. The results point out that the
three pathogens exhibit similar responses to the treatment.
Overall, the three strains had low dispersity time values for
both the correlation plots and the histograms, with final times
below 2000 s (Table S2).
Bacterial Phenotypic Heterogeneity. As seen in Figure
4, column a, the scatter plots indicate that the major
population heterogeneity in E. coli was observed with
compound 3. The population dispersion rates ranged from
∼500 to 5500 s, accounting for a gap of ∼5000 s between the
first and the last inactivated bacteria (Table 2, final times,
range). This effect is better visualized in column b, where the
histograms show 52% overlaps between the initial and final
incorporation times and large dispersion of bacterial death
times. The same bacterial heterogeneity was observed in P.
aeruginosa treated with compound 3 (Figure S4). On the other
hand, we found localized trends with less heterogeneity and
smaller time windows when compounds 1 and 2 were
employed as the PSs (Figure 4, first and second rows). In
these experiments, histogram overlapping was ∼35% in both
cases, and the final times for complete PI incorporation went
from 200 to 2200 s for compound 1 and from 800 to 2900 s
for compound 2 (Table 2). On average, these two PSs killed
∼2 times faster than compound 3. Treatment with compound
4 also exhibited a localized bacterial population, with a gap
time 1.8 times larger than those of compounds 1 and 2 and 1.3
times smaller than that of compound 3 (Table 2, final time,
mean values). Although compound 4 has less dispersity than
PS 3, it presents the longest survival times.
Conversely, the widest population distribution and the
longest death times in MRSA were observed when the Gram-
positive bacteria were treated with compound 4 (Figure 4 and
Table 2). In this case, the difference between the initial and
final times was 4.5, 9.5, and 1.7 times bigger than those for
compounds 1, 2, and 3, respectively (Table 2). For this strain,
Compound 2 showed the lowest bacterial phenotypic
heterogeneity (Figure 4, MRSA, column b), and the difference
between the first and the last inactivated bacterium was only 97
s (Table 2, final times, range). Compound 4 presented
intermediate dispersity in the scatter plot and the largest full
width half maximum for the Gaussian shape.
Membrane Damage and PI Incorporation Times. As
described above, squares that represent a unique bacterial
behavior clearly deviate from a slope of 1 (continuous black
line) in the scatter plots in Figure 4, indicating that there is a
specific PI incorporation period for each bacterium. This lag
time is further evidence of phenotypic differences expressed in
cell wall composition. To extend the analysis further, we
studied the correlation between Δt (defined in Figure 2) and
the final time results that are shown in Figure S5. Figure S5 is
composed of scatter plots; the columns depict the PS used for
the inactivation, and the rows correspond to the bacterial strain
and are highlighted with specific colors. As can be appreciated
in all the plots, bacteria with short survival times have small PI
incorporation periods, whereas the opposite takes place for
bacteria with long inactivation times. This is better observed in
the inset of Figure S5, where the normalized intensity versus
final time profile is represented for two bacteria with different
phenotypes but from the same population under therapy. For
instance, a bacterium with a survival time (black trace) of 1080
s has Δt = 340 s, and a bacterium with a survival time of 3240 s
(orange trace) has Δt = 1036 s. These tendencies are linearly
related by eq S2. Furthermore, the plots in Figure S5 also
indicate that there is a singular slope to be applied in eq S2 for
every experimental condition (e.g., for E. coli treated with
compound 1, the slope is 2.47, and for MRSA treated with
compound 3, the slope is 1.21). In general, correlations for
each bacterial strain provided values between ∼1 and 3,
depending on the PS used. Accordingly, with eq S2, the death
time for an E. coli bacterium treated with PS 1 is going to be
given by 2.47 multiplied by the incorporation time (final time
= 2.47 × Δt). Of course, incorporation times also vary
according to bacterial strain and the potential of the PS to
achieve membrane damage. This experimental evidence
certainly demonstrates that within the same therapeutic
conditions, a bacterium with higher phenotypic resistance
can endure the treatment for longer periods. Thus, membrane
damage seems to be less severe allowing slower PI
incorporation compared with that in vulnerable individuals.
Comparing bacterial strains as a consequence of the cell wall
composition (discussed above, mean values in Table 2 under
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Δt) indicates that incorporation times are on average 17, 10, 7,
and 4 times faster for MRSA than for E. coli, advancing from
compound 1 to 4. Moreover, the binding and photooxidative
effectiveness of the PSs are also reflected in PI incorporation
times. As can be appreciated in Table 2, for both bacterial
strains, compounds 1 and 2 have the shortest incorporation
periods in all cases, followed by compounds 3 and 4.
Bacterial PDI under Cell Growth Conditions. The
advantages of this imaging technique are not only simplicity
and real-time cell death monitoring. It also permitted us to
monitor cells in growth conditions and in a potential first stage
of biofilm formation, in which a bacterium finds a substrate
and attaches to it in a reversible form that becomes an
irreversible state.55,56 This system allows cells to start signaling
to continue biofilm aggregation. Biofilms are the principal
cause of antibiotic treatment failure because of their ability to
protect cells inside the matrix from environmental threats.57
As a step forward, we provided bacteria with adequate
medium to grow. Minimal medium (M-9) was used as the
working solution instead of regular PBS saline buffer. These
results are shown in the last row of Figure S3 (E. coli + M-9)
and are converted to the numbers shown in Table 2 (E. coli +
M-9). We chose compound 1 for this experiment because of its
efficacy. After treatment with compound 1, E. coli population
death time heterogeneity and bacterial survival times increased
significantly with this source of energy, although PS binding
was similar (see Table S1). The final time ranges and mean
values were ∼3 times longer than those for E. coli in PBS saline
buffer. Moreover, the PI incorporation time also increased by a
factor of 1.3. These data manifest how bacteria are less
vulnerable to therapy in growth conditions and how they can
behave in real scenarios.
Time−Kill Curve Profiles in PDI. Time−kill curve profiles
allow the classification of antibiotics as bactericidal or
bacteriostatic compounds when the specific molecular target
is unknown.58 Likewise, the different antibiotic targets indicate
the bacterial responses to the treatment, and these curves can
be used to asses useful antibiotic combination for facing MDR
bacteria in hospitals.59 Also, these curves are applied to
estimate regrowth of in vitro and in vivo models.60 However,
the curves do not give insights into single bacterium
phenotypic behavior in response to the antibiotic therapy.
Starting out from this premise, we focused our endeavor on
demonstrating the existence of vulnerable and more resistant
subpopulations in PDI and on describing, at the single
bacterium level, the outline of the time−kill curve. Up to now,
according to our knowledge, there is not strong experimental
evidence in the literature that supports this theory, particularly
in the PDI field. We believed that our experimental technique
could provide further contributions in this regard. Sub-
Figure 5. Correlation between bacteria and final times (top rows) and time−kill curves (bottom rows) for E. coli (light blue) and MRSA (light
red). Columns represent the PS used in the treatment. Time−kill curve profiles are shown with the following encoding symbols: bacteria and light
(basal condition), ●; bacteria and PS in the dark (PS control), ▲; bacteria with PS and light (PDI treatment), ■. Results represent means ±
standard deviations (SD) from three independent experiments. The light doses employed to eliminate the bacterial populations in the time−kill
curve experiments for E. coli were 1.5, 3, 12, and 12 J/cm2 for compounds 1, 2, 3, and 4, respectively, whereas MRSA needed 0.6, 1.2, 0.6, and 1.2 J/
cm2 light doses for compounds 1, 2, 3, and 4, respectively.
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sequently, we compared our microscopically acquired exper-
imental data with time−kill curves. To simulate the conditions
used in our experiments at the single bacterium level, we kept a
genetically identical population by inoculating a single colony
from a pure culture. After incubation at 37 °C for 16 h and
dilution to 106 CFU/mL, we proceeded with a conventional
inactivation experiment that involved the plotting of time−kill
curves.
These data are represented in Figure 5, which shows the
single bacterium data analysis and the time−kill curves for E.
coli (light blue rows) and MRSA (light orange rows). Also, the
PSs used for each treatment are specified on each column. As
can be appreciated in this figure, both phenotypic hetero-
geneity and PS effectiveness show surprisingly accurate
matching results for both individual bacteria and planktonic
bulk experiments. As previously mentioned, compounds 1 and
2 were the most efficient PSs, inactivating both Gram-positive
and Gram-negative bacteria. This tendency continued in the
time−kill curves, in which the log10 CFU versus time profiles
for compounds 1 and 2 presented the steepest slopes for E.
coli, followed by those for compounds 4 and 3. The largest
range of phenotypic heterogeneity treatment resistance for
compound 3 is reflected in the softest slope. Thus, photo-
inactivation slowly decreases with the initial death of the more
labile population at short time intervals, which is followed by
the death of more resistant microbes at longer times. Time−
kill profiles for the inactivation of MRSA (Figure 5) indicate
fast inactivation times and small phenotypic treatment
resistance for compounds 1 and 2, evidenced by an abrupt
slope and short killing time results that correlated with the
single bacterium experiments. Also, in correlation with the
previous experiments in this manuscript, the inactivation plot
in planktonic culture for compound 4 has a smoother slope,
highlighting phenotypic heterogeneity. Overall, phenotypic
heterogeneity and PS efficiency once again prevailed in
determining killing curve profiles.
Finally, the correlation between our single bacterium
experiments and the time−kill curve assays was corroborated
for E. coli with compound 1 in M-9 minimal medium (Figure
S6). Under these conditions, the time−kill profiles showed
increases in bacterial survival times and a smoother slope,
indicating wider phenotypic heterogeneity in the presence of
the minimal medium as compared with in PBS saline buffer.
■ CONCLUSION
The simple experimental setup used in this work allowed us to
characterize PDI in real-time at the single bacterium level. The
methodology used is mainly based on the capability of a
bacterium to attach to the glass surface, which is directly
related to bacterial growth conditions and pilus formation. The
experimental setup offers a clean alternative with no additional
additives (e.g., polyethylenimine or agarose pads) between
bacteria and surface, avoiding possible dye interactions with
the glass and hence lowering background fluorescence.
Furthermore, the methodology applied herein also permitted
us to evaluate PS efficacy, showing that compounds 1 and 2
were outstandingly effective at inactivating Gram-positive and
Gram-negative bacteria, including ESKAPE members. This is a
point that should be distinguished, because not all PSs have
this versatility in killing pathogens, even when cells are treated
in optimal conditions such as M-9 minimal medium. In
addition, the results gathered for individual bacteria provided
direct and unique experimental evidence that supports the
time−kill curve profiles.
Fluorescence microscopy of an individual cell with
spatiotemporal resolution gives us insight into how a bacterium
can resist PDI treatment according to its distinct phenotype.
Interestingly, no survivors were observed after the irradiation
time selected for each experiment, demonstrating at the single
bacterium level that PDI is a valuable platform for eliminating
pathogens. Like any other individual of any other species on
earth, each bacterium presents unique phenotypic character-
istics and behavior that should be considered to achieve
successful PDI treatments.
■ EXPERIMENTAL SECTION
Materials. All chemicals were purchased from Sigma-
Aldrich (Milwaukee, WI) and used without further purifica-
tion. Tryptic soy broth and agar were purchased from Britania
(Buenos Aires, Argentina).
Instrumentation. UV−visible absorption spectra were
acquired on a Shimadzu UV-2401PC spectrometer (Shimadzu
Corporation, Tokyo, Japan). Luminescence spectra were
recorded using a Spex FluoroMax spectrofluorometer (Horiba
Jobin Yvon Inc., Edison, NJ). Fluence rates were obtained with
a Radiometer Laser Mate-Q (Coherent, Santa Clara, CA).
Photooxidation of DMA and bacterial photoinactivation in
planktonic media were performed using a light-emitting diode
(LED) array that emitted green light at a center wavelength of
510 nm with a fluence rate of 5 mW/cm2. Proton nuclear
magnetic resonance spectra were acquired on a Bruker Avance
300 FT-NMR spectrometer. Mass spectra were measured on a
Bruker micro-TOF-QII spectrometer (Bruker Daltonics, MA)
equipped with an ESI source (ESI-MS). Silica gel thin-layer
chromatography (TLC) plates (250 mm) were acquired from
Analtech (Newark, DE). Silica gel 60 (0.040−0.063 mm, 230−
400 mesh) from Merck (Darmstadt, Germany) was used for
flash column chromatography. Microscopic observations were
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Steady-state fluorescence studies, fluorescence quantum
yields, determination of 1O2 quantum yield (photo-
oxidation of DMA, indirect method), strains and culture
conditions, uptake studies, imaging assays, image
processing, assays with H2DCFDA, biological assays
(antibacterial photodynamic inactivation studies in E.
coli ATCC 25922 and MRSA), control experiments,
synthetic procedures, and characterization of com-
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Tecnoloǵica (FONCyT), Argentina.
■ REFERENCES
(1) Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., and
Piddock, L. J. V. (2015) Molecular mechanisms of antibiotic
resistance. Nat. Rev. Microbiol. 13, 42.
(2) Knopp, M., and Andersson, D. I. (2018) Predictable Phenotypes
of Antibiotic Resistance Mutations. mBio 9 (3), No. e00770-18.
(3) Ventola, C. L. (2015) The antibiotic resistance crisis: part 1:
causes and threats. Pharm. Ther. 40 (4), 277−283.
(4) Zhang, Q., Lambert, G., Liao, D., Kim, H., Robin, K., Tung, C.-
k., Pourmand, N., and Austin, R. H. (2011) Acceleration of
Emergence of Bacterial Antibiotic Resistance in Connected Micro-
environments. Science (Washington, DC, U. S.) 333 (6050), 1764−
1767.
(5) Burki, T. K. (2018) Superbugs: An Arms Race Against Bacteria.
Lancet Respir. Med. 6 (9), 668.
(6) Turro, N. J., Ramamurthy, V., and Scaiano, J. C. (2012) Modern
Molecular Photochemistry of Organic Molecules, University Science
Books.
(7) Ogilby, P. R. (2010) Singlet oxygen: there is indeed something
new under the sun. Chem. Soc. Rev. 39 (8), 3181−209.
(8) Schweitzer, C., and Schmidt, R. (2003) Physical mechanisms of
generation and deactivation of singlet oxygen. Chem. Rev. 103 (5),
1685−757.
(9) Ziegelhoffer, E. C., and Donohue, T. J. (2009) Bacterial
responses to photo-oxidative stress. Nat. Rev. Microbiol. 7 (12), 856−
63.
(10) Finkel, T., and Holbrook, N. J. (2000) Oxidants, oxidative
stress and the biology of ageing. Nature 408, 239.
(11) Phaniendra, A., Jestadi, D. B., and Periyasamy, L. (2015) Free
radicals: properties, sources, targets, and their implication in various
diseases. Indian J. Clin. Biochem. 30 (1), 11−26.
(12) Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-i.,
Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J.,
Hammes, H.-P., Giardino, I., and Brownlee, M. (2000) Normalizing
mitochondrial superoxide production blocks three pathways of
hyperglycaemic damage. Nature 404, 787.
(13) Nemoto, S., Takeda, K., Yu, Z. X., Ferrans, V. J., and Finkel, T.
(2000) Role for mitochondrial oxidants as regulators of cellular
metabolism. Mol. Cell. Biol. 20 (19), 7311−7318.
(14) Brauner, A., Fridman, O., Gefen, O., and Balaban, N. Q. (2016)
Distinguishing between resistance, tolerance and persistence to
antibiotic treatment. Nat. Rev. Microbiol. 14, 320.
(15) Davies, J., and Davies, D. (2010) Origins and evolution of
antibiotic resistance. Microbiology and molecular biology reviews:
MMBR 74 (3), 417−33.
(16) Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., and Leibler, S.
(2004) Bacterial Persistence as a Phenotypic Switch. Science
(Washington, DC, U. S.) 305 (5690), 1622−1625.
(17) Kussell, E. L., Kishony, R., Balaban, N. Q., and Leibler, S.
(2005) Bacterial persistence: a model of survival in changing
environments. Genetics 169, 1807.
(18) Lewis, K. (2007) Persister cells, dormancy and infectious
disease. Nat. Rev. Microbiol. 5, 48.
(19) Pulzova, L., Navratilova, L., and Comor, L. (2017) Alterations
in Outer Membrane Permeability Favor Drug-Resistant Phenotype of
Klebsiella pneumoniae. Microb. Drug Resist. 23 (4), 413−420.
(20) Soto, S. M. (2013) Role of efflux pumps in the antibiotic
resistance of bacteria embedded in a biofilm. Virulence 4 (3), 223−
229.
(21) Williams, S., Hong, Y., Danavall, D., Howard-Jones, M., Gibson,
D., Frischer, M., and Verity, P. (1998) Distinguishing between living
and nonliving bacteria: evaluation of the vital stain propidium iodide
and its combined use with molecular probes in aquatic samples. J.
Microbiol. Methods 32 (3), 225−236.
(22) Kramer, C. E., Wiechert, W., and Kohlheyer, D. (2016) Time-
resolved, single-cell analysis of induced and programmed cell death via
non-invasive propidium iodide and counterstain perfusion. Sci. Rep. 6,
32104.
(23) Johnson, M. B., and Criss, A. K. (2013) Fluorescence
microscopy methods for determining the viability of bacteria in
association with mammalian cells. J. Visualized Exp. No. 79, e50729.
(24) Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E.,
Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., and Bartlett, J.
(2009) Bad bugs, no drugs: no ESKAPE! An update from the
Infectious Diseases Society of America. Clin. Infect. Dis. 48 (1), 1−12.
(25) Agazzi, M. L., Ballatore, M. B., Reynoso, E., Quiroga, E. D., and
Durantini, E. N. (2017) Synthesis, spectroscopic properties and
photodynamic activity of two cationic BODIPY derivatives with
application in the photoinactivation of microorganisms. Eur. J. Med.
Chem. 126, 110−121.
(26) Reynoso, E., Quiroga, E. D., Agazzi, M. L., Ballatore, M. B.,
Bertolotti, S. G., and Durantini, E. N. (2017) Photodynamic
inactivation of microorganisms sensitized by cationic BODIPY
derivatives potentiated by potassium iodide. Photochem. Photobiol.
Sci. 16 (10), 1524−1536.
(27) Kamkaew, A., Lim, S. H., Lee, H. B., Kiew, L. V., Chung, L. Y.,
and Burgess, K. (2013) Chem. Soc. Rev. 42 (1), 77−88.
(28) Yogo, T., Urano, Y., Ishitsuka, Y., Maniwa, F., and Nagano, T.
(2005) Highly efficient and photostable photosensitizer based on
BODIPY chromophore. J. Am. Chem. Soc. 127 (35), 12162−3.
(29) Lu, Z. T., Zhang, X. G., Wu, Z. M., Zhai, T. T., Xue, Y. A., Mei,
L., and Li, C. X. (2014) BODIPY-based macromolecular photo-
sensitizer with selective recognition and enhanced anticancer
efficiency. RSC Adv. 4 (37), 19495−19501.
(30) Ma, J., Yuan, X. L., Kucukoz, B., Li, S. F., Zhang, C. S.,
Majumdar, P., Karatay, A., Li, X. H., Yaglioglu, H. G., Elmali, A., Zhao,
J. Z., and Hayvali, M. (2014) Resonance energy transfer-enhanced
rhodamine-styryl Bodipy dyad triplet photosensitizers. J. Mater. Chem.
C 2 (20), 3900−3913.
(31) Guo, S., Ma, L. H., Zhao, J. Z., Kucukoz, B., Karatay, A.,
Hayvali, M., Yaglioglu, H. G., and Elmali, A. (2014) BODIPY triads
triplet photosensitizers enhanced with intramolecular resonance
energy transfer (RET): broadband visible light absorption and
application in photooxidation. Chem. Sci. 5 (2), 489−500.
(32) Durantini, A. M., Greene, L. E., Lincoln, R., Martıńez, S. R., and
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